Approvals/TGA/AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe within a pen injector

Approved

STANDARD

AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe within a pen injector

Amgen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3985fdbdde71b2b3
Product Name: AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe within a pen injector
Artg Id: 273536
Artg Name: AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe within a pen injector
Sponsor: Amgen Australia Pty Ltd
Company Detail Path: /organization/amgen-australia-pty-ltd
Artg Date: 2017-11-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/34051bb93ae1aa1415176fd8b58bdf5d.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/c4e60db6aecdd22e4f1640c7818ddaec.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

3985fdbdde71b2b3

Type

Standard